Acquisitions - Narrative (Details) € in Thousands															1 Months Ended		3 Months Ended	12 Months Ended
	Dec. 19, 2016 USD ($) shares	Jul. 06, 2016 USD ($)	Feb. 04, 2016 USD ($)	Dec. 04, 2015 USD ($)	Sep. 29, 2015 USD ($)	Jul. 17, 2015	Jul. 14, 2015 USD ($)	Jul. 01, 2015 USD ($)	Mar. 26, 2015 USD ($)	Nov. 25, 2014 EUR (€)	Aug. 08, 2014 USD ($)	Jul. 15, 2014 USD ($)	May 08, 2014 USD ($) shares	Aug. 21, 2012	Jan. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2016 USD ($) shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Aug. 19, 2015 USD ($) shares
Business Acquisition [Line Items]
Payments to acquire intangible assets																		$ 2,217,000	$ 1,956,000	$ 1,714,000
Goodwill acquired																		27,373,000	60,000
Acquired in-process research and development																		461,000	1,000,000	0
Cash paid in acquisitions, net of cash acquired																		125,161,000	12,368,000	5,927,000
DFINE, Inc.
Business Acquisition [Line Items]
Consideration paid		$ 97,500,000
Consideration paid related to net working capital adjustment		578,000
Reduction of purchase price																	$ 1,100,000
Measurement period adjustment, reduction in inventories																	89,000
Measurement period adjustment, reduction in property and equipment																	109,000
Measurement period adjustment, reduction in goodwill																	1,200,000
Measurement period adjustment, reduction in accrued expenses																	407,000
Measurement period adjustment, increase in deferred tax liabilities																	(113,000)
Net sales related to acquisition																		13,500,000
Trade receivables acquired, gross		4,300,000
Trade receivables, expected to be uncollectible		$ 224,000
Weighted average useful life		14 years 10 months
HeRO®Graft
Business Acquisition [Line Items]
Consideration paid			$ 18,500,000
Weighted average useful life			9 years 9 months 25 days
Income since acquisition date																		7,100,000
Xablecath Inc.
Business Acquisition [Line Items]
Number of units acquired | shares																					116,279
Percent owned																					14.00%
Cost method investment																					$ 300,000
Quellent, LLC
Business Acquisition [Line Items]
Consideration paid							$ 1,000,000
Payments to acquire intangible assets																		500,000
Accrued purchase obligation																		500,000
Noncurrent contingent consideration																	270,000	270,000
Goodwill acquired																		60,000
Limited Liability Company
Business Acquisition [Line Items]
Payments to acquire investment												$ 752,000
GMedix
Business Acquisition [Line Items]
Payments to acquire investment													$ 1,800,000
Number of units acquired | shares													737,628
Percent owned													19.00%
Cash paid in acquisitions, net of cash acquired																			1,450,000	$ 350,000
License agreements
Business Acquisition [Line Items]
Intangible Assets																	17,273,000	17,273,000	16,671,000
License agreements | Limited Liability Company
Business Acquisition [Line Items]
Useful life												10 years
Developed technology
Business Acquisition [Line Items]
Intangible Assets																	135,358,000	135,358,000	69,861,000
Developed technology | DFINE, Inc.
Business Acquisition [Line Items]
Useful life		15 years
Developed technology | HeRO®Graft
Business Acquisition [Line Items]
Useful life			10 years
Developed technology | Quellent, LLC
Business Acquisition [Line Items]
Intangible Assets																	1,210,000	1,210,000
Useful life							13 years
Customer Lists
Business Acquisition [Line Items]
Intangible Assets																	6,860,000	6,860,000	5,770,000
Customer Lists | DFINE, Inc.
Business Acquisition [Line Items]
Useful life		9 years
Customer Lists | HeRO®Graft
Business Acquisition [Line Items]
Useful life			12 years
Distribution agreements
Business Acquisition [Line Items]
Intangible Assets																	3,099,000	3,099,000	2,773,000
Trademarks
Business Acquisition [Line Items]
Intangible Assets																	9,050,000	9,050,000	4,705,000
Trademarks | DFINE, Inc.
Business Acquisition [Line Items]
Useful life		15 years
Trademarks | HeRO®Graft
Business Acquisition [Line Items]
Useful life			5 years 6 months
Medical Company 1 | License agreements
Business Acquisition [Line Items]
Useful life				12 years
Payments to acquire intangible assets				$ 500,000
Medical Company 1 | Additional Payments for License Agreement Milestone | License agreements
Business Acquisition [Line Items]
Payments to acquire intangible assets																		1,500,000
Blockade Medical LLC
Business Acquisition [Line Items]
License agreements																	2,700,000	2,700,000
Blockade Medical LLC | License agreements
Business Acquisition [Line Items]
Useful life					10 years
LeMaitre Vascular, Inc. | Developed technology
Business Acquisition [Line Items]
Useful life						10 years
Payments to acquire intangible assets																		400,000
Catch Medical, LLC
Business Acquisition [Line Items]
Payments to acquire intangible assets																		400,000
Accrued purchase obligation																		200,000
Acquired in-process research and development								$ 1,000,000
Long term purchase obligations																		400,000
Distal Access, LLC | License agreements
Business Acquisition [Line Items]
Intangible Assets								$ 3,500,000
Useful life								6 years
Payments to acquire intangible assets																		3,500,000
Teleflex Incorporated
Business Acquisition [Line Items]
Future payments under agreement									$ 400,000
Teleflex Incorporated | Customer Lists
Business Acquisition [Line Items]
Useful life									5 years
Payments to acquire intangible assets																		400,000
Catheter Connections, Inc. | Distribution agreements
Business Acquisition [Line Items]
Useful life														10 years
Payments to acquire intangible assets															$ 250,000
Medical Company 2
Business Acquisition [Line Items]
Payments to acquire intangible assets																$ 624,800		1,100,000
Contingent liability | €										€ 500
Medical Company 2 | License agreements
Business Acquisition [Line Items]
Useful life										10 years
Medical Company 3
Business Acquisition [Line Items]
Payments to acquire intangible assets																		3,500,000	$ 3,000,000
Liabilities incurred																	$ 1,000,000	1,000,000
Medical Company 3 | License agreements
Business Acquisition [Line Items]
Useful life											12 years
Intangible assets											$ 6,300,000
Medical Company 3 | Distribution agreements
Business Acquisition [Line Items]
Useful life											3 years
Intangible assets											$ 200,000
Cost-method Investments | Blockade Medical LLC
Business Acquisition [Line Items]
Consideration paid related to net working capital adjustment					$ 1,000,000
Loans Receivable | Blockade Medical LLC
Business Acquisition [Line Items]
Consideration paid related to net working capital adjustment					$ 1,700,000
Cardiovascular Segment | DFINE, Inc.
Business Acquisition [Line Items]
Acquisition-related costs																		1,600,000
Investee | Bluegrass Vascular Technologies, Inc.
Business Acquisition [Line Items]
Payments to acquire investment	$ 5,000,000
Number of units acquired | shares	1,251,878
Percent owned	19.50%
Cost method investment	$ 4,000,000
Investee | Bluegrass Vascular Technologies, Inc. | Distribution agreements
Business Acquisition [Line Items]
Intangible Assets	$ 1,000,000
Useful life	3 years
Limited Liability Company | Cagent Vascular, LLC
Business Acquisition [Line Items]
Payments to acquire investment																		$ 3,000,000
Number of units acquired | shares																	2,965,000	2,965,000
Percent owned																	19.94656%	19.94656%